04546nam a22005895i 4500 978-3-031-65650-7 DE-He213 20251030113320.0 cr nn 008mamaa 241120s2024 sz | s |||| 0|eng d 9783031656507 978-3-031-65650-7 10.1007/978-3-031-65650-7 doi RC799-869 MNG bicssc MED031000 bisacsh MNG thema Dysbiosis [electronic resource] : Correlation between Changes in Microbiota and Pathology / edited by Jaime Ruiz-Tovar. 1st ed. 2024. Cham : Springer Nature Switzerland : Imprint: Springer, 2024. V, 144 p. 13 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Microbiota, Microbiome,Applied technologies and omics techniques applied to the microbiota. Metagenomics -- Use of Probiotics, Prebiotics, Symbiotics,Postbiotics,Nutrition and microbiota -- Microbiota and neurodegenerative and brain diseases -- Microbiota and diseases associated with the digestive system.-Microbiota and diseases associated with rheumatic and autoimmune diseases -- Microbiota and diseases associated with metabolic syndrome -- Microbiota and diseases associated with the cardiovascular system -- Microbiota and gynaecological diseases -- Microbiota and cancer -- Microbiota and dermatological diseases -- Microbiota in Neonatology and Paediatrics -- Microbiota and diseases associated with ageing. This book discusses in detail the pathological aspects associated with alterations in the gut microbiota and the pathogenesis of different disorders related to dysbiosis. The volume describes the impact of dysbiosis on organs other than the gut and brain, such as metabolic diseases, cancer, gynecologic disorders, aging, or pediatric pathologies. Additionally, it associates the mechanisms and metabolic signaling pathways related to gut microbiota homeostasis and alterations with their clinical impact, highlighting the importance of translational research on dysbiosis. The volume is divided into 12 chapters: the first two chapters present diagnostic methods and therapeutic options, including prebiotics and probiotics. The remaining ten chapters specifically focus on diseases of different organs. Moreover, the relevance of these findings to precision medicine will be discussed. The book provides biomedical professionals, basic researchers, and clinical practitioners, especially those specialized in Precision Medicine and Integrative Medicine, with information about the effects of dysbiosis on the physiopathology of various diseases. It also includes updated evidence on the impact of dysbiosis on numerous pathologies, such as metabolic diseases, cancer, gynecologic disorders, aging, or pediatric pathologies, going beyond gastrointestinal and central nervous system diseases typically covered in many publications. Furthermore, the book addresses the translational aspect of dysbiosis. It starts with the basic research knowledge on dysbiosis and disease and aims to provide a translational approach applicable to clinical practice. By combining the fundamental knowledge of biomedical researchers with the clinical applicability of healthcare practitioners, this book bridges the gap between theory and practice. Gastroenterology. 76519 Metabolism Disorders. 78415 Oncology. 70760 Gynecology . 64086 Geriatrics. 64200 Pediatrics. 64087 Gastroenterology. 76519 Metabolic Disease. 78417 Oncology. 70760 Gynecology. 64086 Geriatrics. 64200 Pediatrics. 64087 Ruiz-Tovar, Jaime. editor. edt http://id.loc.gov/vocabulary/relators/edt 87759 SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031656491 Printed edition: 9783031656514 Printed edition: 9783031656521 https://doi.org/10.1007/978-3-031-65650-7 ZDB-2-SME ZDB-2-SXM 65072 65072